| Name of the Investigator |
Title of the project and duration |
Amount sanctioned |
Funding Agency
|
| D. P. Yogeeswari |
Synthesis and Neuropharmacology of 4-Aminobutyric Acid Analogues 2005-2009 |
8,96,000 |
CSIR |
| Dr. D. Sriram |
Design and Synthesis of Novel Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Aids and Opportunistic Infections associated with Aids including Tuberculosis 2005-2009 |
10,00,000 |
ICMR |
| D. P. Yogeeswari |
Design and synthesis of newer gaba analogues for treating cns disorders 2007-2010 |
8,35,413 |
UGC |
| Dr. D. Sriram & Dr. P. Yogeeswari |
Design and synthesis of inhibitors of various enzymes of mycobacterium tuberculosis like dna gyrase and topoisomerase –I 2007-2012 |
39,56,000 |
DBT Centre of Excellence project |
| Dr. D. Sriram & Dr. P. Yogeeswari |
Structure-guided Design of New Antibacterial Agents against Dormant Mycobacterium Tuberculosis 2010-2013 |
64,88,000 |
DBT Indo-Sweden joint program |
| Dr. D. Sriram |
Isocitrate lyase Enzyme as Target in Persistent Mycobacterium tuberculosis Infection: Synthesis of 2-Arylthiazolidine-4-carboxylic acid and 5-Nitro-2-furoric acid Derivatives and its Antimycobacterial Evaluation 2009-2012 |
10,22,000 |
UGC |
| Dr. D. Sriram |
Design and Synthesis of New Inhibitors of MTB GlmU by modeling & high throughput docking 2010-2011 |
31,71,000 |
Open Source Drug Discovery-CSIR |
| Dr. D. Sriram |
Development of Library of Heterocyclic Compounds for the Treatment of Tuberculosis - Multi-Drug resistant tuberculosis and persistent tubrculosis (Modified version) 2011-2014 |
23,80,000 |
DST |
| Dr. D. Sriram |
Development of Novel DNA Gyrase Inhibitors against Mycobacterium Tuberculosis and other Non-tuberculosis Mycobacterial Infections 2010-2013 |
16,76,000 |
CSIR |
| Dr. P. Yogeeswari |
Inhibition of the Protease of Peripheral Macrophages and Microglial Cells in the Spinal Cord for the Treatment of Neuropathic Pain 2011-2013 |
31,12,000 |
DBT- Neuroresearch project |
| Dr. Punna Rao |
Design, Characterization and Pharmacokinetic Evaluation of Nanocarriers for Antiretroviral Drug Delivery in the Effective Treatment of HIV/AIDS |
26,00,000 |
DST- Fast track for young scientist |
| Dr. Punna Rao |
Design, pharmacokinetic and pharmacodynamic evaluation of nanocarriers for selective estrogen receptor modulator delivery in the effective treatment of postmenapausal osteoporesis |
7,83,000 |
UGC |
| Dr. P. Yogeeswari |
Discovery of novel modulators of NAD (+) dependant protein deacetylase sirti for the treatment of various human disorders 2011-2014 |
30,00,000 (yet to be sanctioned) |
DBT |
| Dr. P. Yogeeswari |
Drug discovery of inhibitors of the cathepsin S in the spinal cord for the treatment of neuropathic pain 2011-2014 |
35,00,000 (yet to be sanctioned) |
DST |
| Dr. D. Sriram & Dr. P. Yogeeswari |
Development, synthesis and testing of novel anti-HIV drugs |
65,00,000 (yet to be sanctioned) |
DST Indo-Brazillian-South African tripartate project |
| Dr. A. Sajeli Begum |
Quality control studies on safflower petals of different Indian cultivates as per WHO guidelines |
9,44,000 |
UGC |
| Dr. D. Sriram |
Development of Novel Isocitrate Lyase Inhibitors for the treatment of Persistent Tuberculosis 2011-2014 |
15,00,000 (yet to be sanctioned) |
ICMR |